JENNIFER YU: Open Payments
NPI 1851008890 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $222 |
| Alkermes, Inc. | 1 | $127 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $95 |
Products named: LYBALVI, UZEDY, INGREZZA, REXULTI, ABILIFY MAINTENA, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
